-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
May 01, 2012 - higher risk
disease. … Who dies of
http://www.effectivehealthcare.ahrq.gov/reports/final.cfm
20
disease? … progression
36 months No statistically significant
disease progression. … higher risk disease. … Do Not Know
subjects with T2c disease but not in T2b
subjects.
-
effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
May 01, 2012 - higher risk
disease. … Who dies of
http://www.effectivehealthcare.ahrq.gov/reports/final.cfm
20
disease? … progression
36 months No statistically significant
disease progression. … higher risk disease. … Do Not Know
subjects with T2c disease but not in T2b
subjects.
-
effectivehealthcare.ahrq.gov/sites/default/files/pepticulcer_hi_impact.pdf
January 01, 2012 - (The therapy
has also recently been identified as being explored for other autoimmune diseases such … The rationale for this treatment
stems from the fact that inflammatory bowel diseases are rare in developing … The rationale for this treatment stems from the
fact that inflammatory bowel diseases are rare in developing … and other
inflammatory bowel diseases.
8
It does not appear that the manufacturer intends to … Bethesda (MD):
National Digestive Diseases Information
Clearinghouse; [accessed 2011 Jun 6]. [4 p
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/women-hiv_research-protocol.pdf
March 01, 2016 - , chronic kidney disease,
bone disease, hyperlipidemia, cancer, depression, and neurocognitive impairment … This may lead to delayed diagnosis and greater
disease burden for the individual. … Clinical infectious diseases : an official publication of the
Infectious Diseases Society of America … HIV infection and cardiovascular disease. European
heart journal. 2014;35(21):1373-1381.
12. … Psychological symptoms among persons 50 years of age and older living with
HIV disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-incidence_research.pdf
January 01, 2011 - were determined to have diabetes if they had
two or more claims with International Classification of
Diseases … The
former set of ICD-9 codes represents the following
macrovascular diseases: peripheral arterial … disease,
myocardial infarction, heart failure, angina, and cere-
brovascular disease. … The latter set of ICD-9 codes
represents the following microvascular diseases: diabetic
renal disease … , diabetic ophthalmic disease, and diabetic
neurologic disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-treatment_executive.pdf
August 01, 2012 - – Coronary disease risk factors such as diabetes,
chronic kidney disease, or other comorbid disease? … – Coronary disease risk factors such as diabetes,
chronic kidney disease, or other comorbid disease? … – Coronary disease risk factors such as diabetes,
chronic kidney disease, or other comorbid disease? … • Coronary disease risk factors such as diabetes,
chronic kidney disease, or other comorbid
disease … Ischemic heart disease in women: facts and wishful
thinking.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine-1_research.pdf
February 01, 2009 - rheumatoid arthritis, disease modifying anti-rheumatic drugs, epidemiology
Effective Health Care … Research Report Number 8
Introduction
The treatment of rheumatoid arthritis (RA) with disease modifying … anti-rheumatic drugs
(DMARDs) provides control of disease activity, slows joint erosions and improves … remission after 3 years.9,10 The
lack of information on disease duration or disease activity measurements … The changing
use of disease-modifying anti-rheumatic drugs in
individuals with rheumatoid arthritis
-
effectivehealthcare.ahrq.gov/sites/default/files/searching.ppt
January 01, 2011 - Searches would include the disease, intervention, and terms for RCTs. … However, it is also sufficient to include the intervention, harms, and the disease of interest. … Arterial occlusive disease/
Peripheral vascular diseases/
Vascular diseases/
Atherosclerosis/
Cardiovascular … diseases/
Carotid artery diseases/
(((preserved adj left) or (stable adj cad) or (stable adj chd) or … adj lvef) or (normal adj ef)).mp
1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10
Terms for vascular diseases
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary_hi_impact.pdf
April 01, 2012 - Horizon Scanning System – Potential High
Impact Interventions Report
Priority Area 13: Pulmonary Disease … ES-2
Pulmonary Disease, Including Asthma, Interventions ........................................... … ES-2
AHRQ Healthcare
Horizon Scanning System
AHRQ Priority Area 13 – Pulmonary Disease … Priority Area 13: Pulmonary Disease (including Asthma)
1. … Roflumilast (Daliresp) for treatment of chronic obstructive pulmonary disease
Discussion
Pulmonary
-
effectivehealthcare.ahrq.gov/sites/default/files/branson-text.pdf
October 13, 2011 - providers
Slide 4
Characteristics of Patient Representatives
§ Have personal experience with the disease … § Are knowledgeable about treatment options and/or the science of the disease
§ Are able to be objective … groups may offer an opportunity to identify patients who
might be underrepresented (such as for rare diseases … Advocacy experience
§ Ability to represent other patients/survivors
§ Knowledge and skills related to disease … area
§ Alternate disease experience
§ Work experience
§ Education
§ Interview representatives.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
April 01, 2013 - 1.4.2 HIV infection
1.4.3 Portal hypertension
1.4.4 Congenital heart diseases … dysfunction
2.3 Valvular disease
3. … Pulmonary hypertension owing to lung diseases and/or hypoxemia
3.1 Chronic obstructive pulmonary … disease
3.2 Interstitial lung disease
3.3 Other pulmonary diseases with mixed restrictive … , or
chronic obstructive pulmonary disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/bladder-cancer-non-muscle-invasive_research-protocol.pdf
July 21, 2014 - such as age,
sex, ethnicity, performance status, or medical comorbidities such as chronic
kidney disease … We will exclude studies of biomarkers for prediction of
treatment response or disease progression. … While identification of biomarkers for
predicting treatment response and disease progression are important … Department of
Health and Human Services, Centers for Disease Control and Prevention and
National Cancer … heading word, keyword heading word, protocol supplementary concept word, rare
disease
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-anticholinergic-medicines_research.pdf
December 01, 2009 - for markers of
disease severity differences may remain between groups. … A 4-
year trial of tiotropium in chronic
obstructive pulmonary disease. … A 4-
year trial of tiotropium in chronic
obstructive pulmonary disease. … Tiotropium for stable chronic
obstructive pulmonary disease: A meta-
analysis. … A 4-
year trial of tiotropium in chronic
obstructive pulmonary disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/s158.pdf
October 01, 2007 - Availability of information on disease outcome will affect
choice of analytic strategies. … limitations when they are
used to assess the role of medications in the etiology and
management of chronic diseases … not have been completely
controlled for in observational studies on pharmacopreven-
tion of chronic diseases … These
databases are, however, often the best source of information
on the association between drugs and diseases … The treatment of unrelated disor-
ders in patients with chronic medical diseases.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes-2007.pdf
January 01, 2007 - Atherosclerotic
renovascular disease in United States patients aged
67 years or older: risk factors … Progression
of atherosclerotic renovascular disease: A prospective
population-based study. … Atherosclerotic renovascular disease: medical
therapy versus medical therapy plus renal artery
stenting … stage 3A, baseline GFR 41-59 mL/min
2 Chronic kidney disease stage 3A, baseline GFR 30-40 mL/min
3 … ARAS, atherosclerotic renal artery stenosis; CKD, chronic kidney disease; CVD, cardiovascular disease
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0278_03-10-2008.pdf
January 01, 2008 - 09
1
Results of Topic Selection Process & Next Steps
Clostridium difficile-associated disease … in-hospital infection
control, appropriate antibiotic prescribing, and effective treatment of existing disease … Clostridium difficile-associated disease (CDAD)
Nomination Summary Document
http://effectivehealthcare.ahrq.gov
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-diabetes-rapid-research.pdf
November 01, 2024 - , including lower limb
amputations, blindness, chronic kidney disease, and cardiovascular diseases.5 … , gingival infection, periodontal disease, and tooth loss.4 They are among the most
common chronic diseases … and cardiovascular
diseases, diabetes,
and respiratory
diseases: Summary
of the consensus
report … Periodontal Diseases
and Cardiovascular Diseases, Diabetes, and
Respiratory Diseases: Summary of the … Wrong study design
Choi 2020 31882408 Impact of Treating Oral
Disease on Preventing
Vascular Diseases
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/catd-protocol-draft_0.pdf
November 02, 2018 - Most
individuals with dementia have Alzheimer’s disease (AD) as at least part of their underlying
disease … ), or dementia due to a non-AD neurodegenerative disease. … Alzheimer's Disease. Centers for Disease Control and Prevention. … of Department of Health
and Human Services Task Force on Alzheimer's Disease. … Pharmacological interventions
for apathy in Alzheimer's disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_research-protocol.pdf
March 13, 2012 - diagnosed
with stage II disease are between 58 and 83 percent. … will develop recurrence or die from
their disease. … In this report, prognostic outcomes relate to disease prognosis, generally
measured by rate of disease … o For disease-free survival, how was it determined? … Centers for Disease Control and Prevention Web site. Public Health Genomics.
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/patient-participant-generated-registries-guide-3rd-ed-addendum-white-paper.pdf
February 01, 2018 - Evolution and Variation
The phenomenon of individuals affected by diseases establishing registries … history of a
disease. … able to help generate evidence to support the development of treatment guidelines,
especially for diseases … into care
coordination and practice guidelines has become a model for other diseases.19, 73-84
Planning … Methodology of clinical research in rare
diseases: development of a research program
in juvenile neuronal